1996

EntreMed

EntreMed -Licensed anti-angiogenesis technology. This Technology was developed by Dr. Judah Folkman from Harvard Children’s Hospital. Reached a $1.4 billion market cap during involvement as Chairman. Sold to Casi Pharmaceuticals.